Effects of Pregabalin Ultrasound Therapy and Nerve Exercises on Pain and Sensation in Diabetic Nerve Damage
NCT: NCT07683338 · COMPLETED
Brief Summary
Peripheral diabetic neuropathy (PDN) is a common complication of diabetes mellitus characterized by neuropathic pain, sensory disturbances, and impaired quality of life. This study aims to determine the effects of pregabalin phonophoresis combined with sural nerve flossing on neuropathic pain and sensory function in individuals with peripheral diabetic neuropathy. Participants will be randomly allocated to intervention groups and treated according to the study protocol. Outcomes related to neuropathic pain intensity and sensory function will be assessed before and after the intervention period to evaluate the effectiveness of the combined treatment approach.
Frequently Asked Questions
What is Effects of Pregabalin Ultrasound Therapy and Nerve Exercises on Pain and Sensation in Diabetic Nerve Damage?
Effects of Pregabalin Ultrasound Therapy and Nerve Exercises on Pain and Sensation in Diabetic Nerve Damage is a clinical trial registered under NCT07683338. Current status: COMPLETED.
What is the status of NCT07683338?
The current status of NCT07683338 (Effects of Pregabalin Ultrasound Therapy and Nerve Exercises on Pain and Sensation in Diabetic Nerve Damage) is: COMPLETED.
When did Effects of Pregabalin Ultrasound Therapy and Nerve Exercises on Pain and Sensation in Diabetic Nerve Damage start?
Effects of Pregabalin Ultrasound Therapy and Nerve Exercises on Pain and Sensation in Diabetic Nerve Damage started on 2026-02-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.